One More Update on OSsIRIS Post-Market Clinical Study

The first UK patient in this Post-Market Multicentre Study has been enrolled at Hull Royal Infirmary.

Big thanks to Prof. Sharma and the Orthopaedics Research Team at Hull University Teaching Hospitals NHS Trust for their dedication to enhancing orthopaedic care.

Great milestone for GreenBone

We are excited to announce the enrollment of the first patient for our OSsIRIS study at the University Medical Centre in Regensburg (Germany).

Thank you to the Team at the Department of Trauma Surgery,  led by Prof. Volker Alt, for this significant achievement.

We look forward to many more successful cases ahead.

GreenBone and Mikai are proud to announce their long term partnership to distribute GreenBone’s innovative bone substitute in the Italian market